Ramdevbaba Solvent Fair Value
Fair Value Analysis Export
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
RBS Fair Value Analysis — Data Sources & Coverage
Ramdevbaba Solvent financial data sources, valuation methods applied and sector benchmarks used — 2024 financial year. Examine RBS quarterly performance for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is 2 years old (2024).
RBS vs FMCG Sector Peers — P/E, P/B & Market Cap
Ramdevbaba Solvent P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Sarda Proteins | SRDAPRT | -223.5 | 0.85 | ₹76 |
| Swasth Foodtech | SWASTH | 4.01 | 0.43 | ₹9 |
| Shreeji Global FMCG | SHETHJI | - | 2.55 | ₹286 |
| Evexia Lifecar | EVEXIA | 59.0 | 0.21 | ₹115 |
| Nath Bio-Genes | NATHBIOGEN | 6.27 | 0.42 | ₹291 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.